| 1 September 2023 |
|
Itsarm plc
Appointment of Nominated Adviser and Sole Broker and
Issue of Shares and Total Voting Rights
Itsarm plc (the "Company") is pleased to announce the appointment of Zeus Capital Limited as its Nominated Adviser and Sole Broker, with immediate effect.
The Company also announces the issue of 1,630,612 ordinary shares of 0.25p each in the Company ("Ordinary Shares") in lieu of payment of certain creditors to conserve cash within the business.
The new Ordinary Shares will, when issued, rank pari passu in all respects with the existing Ordinary Shares of the Company. Application will be made for the 1,630,612 new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence at 8:00 a.m. on 8 September 2023 ("Admission").
Following Admission, the total number of voting rights in the Company will be 54,130,610. This figure may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company.
For further enquiries:
| Itsarm plc | Via Hudson Sandler |
| |
| David Craven, Non-Executive Chairman Jean-Paul Rohan, Non-Executive Director | |
| |
| Hudson Sandler | +44 (0)20 7796 4133 | | |
| Alex Brennan Ben Wilson
| itsarm@hudsonsandler.com | | |
| Zeus (Nomad and Broker) David Foreman / Ed Beddows (Investment Banking) | +44 (0) 20 3829 5000
| | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.